Table 1.
Planned US trial enrollment divided by the number of new US cancer patients
| Trial start year | No. of new US cancer patients* | Planned US trial enrollment†/No. of new cancer patients (%) |
||
| NCI-sponsored trials | Other-sponsored trials | Total | ||
| 2005 | 1 349 922 | 2.90 | 3.24 | 6.14 |
| 2006 | 1 375 718 | 2.81 | 3.84 | 6.65 |
| 2007 | 1 406 840 | 2.02 | 4.14 | 6.16 |
| 2008 | 1 437 373 | 1.81 | 3.73 | 5.54 |
| 2009 | 1 464 339 | 1.79 | 4.62 | 6.41 |
| 2005–2009 | 7 034 192 | 2.25‡ | 3.92‡ | 6.18‡ |
*
Based on US Census population data and cancer incidence estimates from the Surveillance, Epidemiology, and End Results Program.
†
From ClinicalTrials.gov.
‡
Percentages for the combined years 2005–2009 given as weighted averages of the annual percentages in the cells above.